← Open Payments lookup

KATHY HEMMING: Open Payments

NPI 1700817442 · AMMON, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$470 in 14 payments from 6 companies in 2025. Trend: 2023 $294 · 2024 $200 · 2025 $470

Food & beverage: $470
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$187
Teva Pharmaceuticals USA, Inc.1$125
Vanda Pharmaceuticals Inc.4$72
ABBVIE INC.3$49
Alkermes, Inc.1$22
Neurocrine BioSciences, Inc.1$15

Products named: CAPLYTA, UZEDY, FANAPT, VRAYLAR, VIVITROL, INGREZZA.

Industry payments across ID — which companies pay providers there.